ArticleDrug design, development and therapy2021

CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA Cancer Vaccine.

Qin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.